Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statement of Changes in Stockholders' Equity (Unaudited)

v3.20.2
Consolidated Statement of Changes in Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2018 $ 116 $ 195,554 $ (186,857) $ 8,813
Balance, shares at Dec. 31, 2018 115,703,044      
Stock-based compensation 316   316
Stock-based compensation, shares 2,221      
Sale of common stock, net of offering costs $ 1 379   380
Sale of common stock, net of offering costs, shares 924,500      
Issuance of common stock from exercise of warrants $ 2 1,502   1,504
Issuance of common stock from exercise of warrants, shares 2,506,271      
Net loss     (5,670) (5,670)
Balance at Mar. 31, 2019 $ 119 197,751 (192,527) 5,343
Balance, shares at Mar. 31, 2019 119,136,036      
Balance at Dec. 31, 2019 $ 165 214,237 (208,758) 5,644
Balance, shares at Dec. 31, 2019 164,701,167      
Stock-based compensation   372 372
Sale of common stock, net of offering costs $ 10 2,664   2,674
Sale of common stock, net of offering costs, shares 10,138,369      
Net loss     (5,670) (5,670)
Balance at Mar. 31, 2020 $ 175 $ 217,273 $ (214,428) $ 3,020
Balance, shares at Mar. 31, 2020 174,839,536